These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2389440)

  • 1. Factors influencing long-term graft function in children with the use of cyclosporine A.
    Hoyer PF; Offner G; Brodehl J; Ringe B; Bunsendahl H; Pichlmayr R
    Transplant Proc; 1990 Aug; 22(4):1711-2. PubMed ID: 2389440
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved results using pediatric cadaver donor kidneys with cyclosporine immunosuppression.
    Hayes JM; Novick AC; Steinmuller DR; Streem SB; Hodge EE; Bretan PN; Cunningham R; Graneto D
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):209-14. PubMed ID: 3291245
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine monotherapy in children: long-term effect.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Oct; 26(5):2610-6. PubMed ID: 7940813
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal function and donor age: five years' experience with cyclosporin A.
    Hoyer PF; Offner G; Brodehl J; Ringe B; Bunzendahl H; Pichlmayr R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1930-1. PubMed ID: 2652628
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimization of cyclosporine monotherapy--long-term graft function.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Oct; 26(5):2501-6. PubMed ID: 7940767
    [No Abstract]   [Full Text] [Related]  

  • 6. Four years' experience with cyclosporine A in pediatric kidney transplantation.
    Hoyer PF; Offner G; Oemar BS; Brodehl J; Ringe B; Pichlmayr R
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):274-9. PubMed ID: 3291256
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
    Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif A; Foda MA
    Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
    [No Abstract]   [Full Text] [Related]  

  • 8. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A; Sells RA; Bakran A; Tewari A
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term results in cadaveric renal transplantation under cyclosporine therapy.
    Land W; Schneeberger H; Schleibner S; Illner WD; Abendroth D; Hillebrand G; Gokel JM; Albert E; Fornara P
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1244-6. PubMed ID: 1989200
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal transplantation in children less than 5 years of age: a single center experience in the cyclosporine era.
    Tydén G; Berg U; Bohlin AB
    Transplant Proc; 1994 Feb; 26(1):93-4. PubMed ID: 8109039
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
    Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
    Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
    [No Abstract]   [Full Text] [Related]  

  • 13. Aggressive early cyclosporine therapy is desirable in pediatric renal transplantation.
    al-Uzri A; Conley SB; Orlandi P; So S; Salvatierra O
    Transplant Proc; 1994 Feb; 26(1):88-90. PubMed ID: 8109036
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppressive factors in patients after donor-specific transfusion with administration of cyclosporine.
    Yuzawa K; Otsuka M; Yu Y; Sharma N; Iwasaki H; Fukao K; Iwasaki Y
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1036-8. PubMed ID: 1824884
    [No Abstract]   [Full Text] [Related]  

  • 15. Remarkable long-term prognosis and excellent growth in kidney-transplant children under cyclosporine monotherapy.
    Klare B; Strom TM; Hahn H; Engelsberger I; Meusel E; Illner WD; Abendroth D; Land W
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1013-7. PubMed ID: 1989142
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine for steroid-resistant acute rejection of renal cadaver grafts.
    Ballardie FW; Winearls CG; Evans DJ; Rees AJ; Williams G
    Transplantation; 1986 Apr; 41(4):537-9. PubMed ID: 3515655
    [No Abstract]   [Full Text] [Related]  

  • 17. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
    Ebel H; Lange H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
    [No Abstract]   [Full Text] [Related]  

  • 18. Rejection and recurrence of SLE nephritis in cyclosporine-treated kidney transplant recipients.
    Nyberg G; Blohmé I; Svalander C; Persson H; Brynger H
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1637-8. PubMed ID: 3274393
    [No Abstract]   [Full Text] [Related]  

  • 19. A 1-year prospective randomized study in Korean living donor kidney transplant recipients: comparing cyclosporine monotherapy and cyclosporine/prednisolone during the maintenance phase of immunosuppression.
    Park K; Kim ST; Lee SR; Koh YB; Kim HC
    Transplant Proc; 1994 Aug; 26(4):1985-6. PubMed ID: 8066642
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression.
    Raine AE; Carter R; Mann JI; Chapman JR; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1820-1. PubMed ID: 3274428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.